{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T14:02:23Z","timestamp":1780322543101,"version":"3.54.1"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,9,30]]},"DOI":"10.7759\/cureus.70517","type":"journal-article","created":{"date-parts":[[2024,9,30]],"date-time":"2024-09-30T14:54:16Z","timestamp":1727708056000},"source":"Crossref","is-referenced-by-count":2,"title":["Coronary Artery Calcification in Rheumatoid Arthritis Patients: A Systematic Review"],"prefix":"10.7759","author":[{"given":"Stephanie","family":"Nagy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jordan","family":"Ditchek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc M","family":"Kesselman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","article-title":"Rheumatoid Arthritis","author":"Chauhan K","year":"2023","unstructured":"Chauhan K, Jandu J, Brent L, et al.. Rheumatoid Arthritis. StatPearls Publishing, Treasure Island (FL); 2023."},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/S2665-9913(23)00211-4","article-title":"Global, regional, and national burden of rheumatoid arthritis, 1990-2020, and projections to 2050: a systematic analysis of the global burden of disease study 2021","volume":"5","year":"2023","unstructured":"Global, regional, and national burden of rheumatoid arthritis, 1990-2020, and projections to 2050. a systematic analysis of the global burden of disease study 2021. Lancet Rheumatol. 2023, 5:e594-610. 10.1016\/S2665-9913(23)00211-4","journal-title":"Lancet Rheumatol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.5582%2Firdr.2021.01022","article-title":"Immunopathogenic mechanisms of rheumatoid arthritis and the use of anti-inflammatory drugs","volume":"10","author":"Zhang L","year":"2021","unstructured":"Zhang L, Zhang Y, Pan J. Immunopathogenic mechanisms of rheumatoid arthritis and the use of anti-inflammatory drugs. Intractable Rare Dis Res. 2021, 10:154-64. 10.5582%2Firdr.2021.01022","journal-title":"Intractable Rare Dis Res"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.3390\/cells7100161","article-title":"Pathogenic role of immune cells in rheumatoid arthritis: implications in clinical treatment and biomarker development","volume":"7","author":"Yap HY","year":"2018","unstructured":"Yap HY, Tee SZ, Wong MM, Chow SK, Peh SC, Teow SY. Pathogenic role of immune cells in rheumatoid arthritis: implications in clinical treatment and biomarker development. Cells. 2018, 7:161. 10.3390\/cells7100161","journal-title":"Cells"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1302\/2046-3758.117.BJR-2021-0594.R1","article-title":"Immunomodulatory role of T helper cells in rheumatoid arthritis: a comprehensive research review","volume":"11","author":"Luo P","year":"2022","unstructured":"Luo P, Wang P, Xu J, Hou W, Xu P, Xu K, Liu L. Immunomodulatory role of T helper cells in rheumatoid arthritis: a comprehensive research review. Bone Joint Res. 2022, 11:426-38. 10.1302\/2046-3758.117.BJR-2021-0594.R1","journal-title":"Bone Joint Res"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.3389%2Ffmed.2018.00339","article-title":"The clinical value of autoantibodies in rheumatoid arthritis","volume":"5","author":"Bugatti S","year":"2018","unstructured":"Bugatti S, Manzo A, Montecucco C, et al.. The clinical value of autoantibodies in rheumatoid arthritis. Front Med. 2018, 5:339. 10.3389%2Ffmed.2018.00339","journal-title":"Front Med"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1515%2Frir-2024-0007","article-title":"Clinical implications of seropositive and seronegative autoantibody status in rheumatoid arthritis patients: a comparative multicentre observational study","volume":"5","author":"Hammam N","year":"2024","unstructured":"Hammam N, El-Husseiny P, Al-Adle S, et al.. Clinical implications of seropositive and seronegative autoantibody status in rheumatoid arthritis patients: a comparative multicentre observational study. Rheumatol Immunol Res. 2024, 5:57-65. 10.1515%2Frir-2024-0007","journal-title":"Rheumatol Immunol Res"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/726598","article-title":"Rheumatoid factors: clinical applications","volume":"35","author":"Ingegnoli F","year":"2013","unstructured":"Ingegnoli F, Castelli R, Gualtierotti R. Rheumatoid factors: clinical applications. Dis Markers. 2013, 35:727-34. 10.1155\/2013\/726598","journal-title":"Dis Markers"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2004.033571","article-title":"Longitudinal analysis of citrullinated protein\/peptide antibodies (anti-CP) during 5 year follow up in early rheumatoid arthritis: anti-CP status predicts worse disease activity and greater radiological progression","volume":"64","author":"R\u00f6nnelid J","year":"2005","unstructured":"R\u00f6nnelid J, Wick MC, Lampa J, Lindblad S, Nordmark B, Klareskog L, van Vollenhoven RF. Longitudinal analysis of citrullinated protein\/peptide antibodies (anti-CP) during 5 year follow up in early rheumatoid arthritis: anti-CP status predicts worse disease activity and greater radiological progression. Ann Rheum Dis. 2005, 64:1744-9. 10.1136\/ard.2004.033571","journal-title":"Ann Rheum Dis"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2021-221733","article-title":"EULAR recommendations for cardiovascular risk management in rheumatic and musculoskeletal diseases, including systemic lupus erythematosus and antiphospholipid syndrome","volume":"81","author":"Drosos GC","year":"2022","unstructured":"Drosos GC, Vedder D, Houben E, et al.. EULAR recommendations for cardiovascular risk management in rheumatic and musculoskeletal diseases, including systemic lupus erythematosus and antiphospholipid syndrome. Ann Rheum Dis. 2022, 81:768-79. 10.1136\/annrheumdis-2021-221733","journal-title":"Ann Rheum Dis"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2016-209775","article-title":"EULAR recommendations for cardiovascular disease risk management in patients with rheumatoid arthritis and other forms of inflammatory joint disorders: 2015\/2016 update","volume":"76","author":"Agca R","year":"2017","unstructured":"Agca R, Heslinga SC, Rollefstad S, et al.. EULAR recommendations for cardiovascular disease risk management in patients with rheumatoid arthritis and other forms of inflammatory joint disorders: 2015\/2016 update. Ann Rheum Dis. 2017, 76:17-28. 10.1136\/annrheumdis-2016-209775","journal-title":"Ann Rheum Dis"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016%2Fj.amjmed.2008.06.011","article-title":"Cardiovascular morbidity and mortality in rheumatoid arthritis","volume":"121","author":"Gabriel SE","year":"2008","unstructured":"Gabriel SE. Cardiovascular morbidity and mortality in rheumatoid arthritis. Am J Med. 2008, 121:9-14. 10.1016%2Fj.amjmed.2008.06.011","journal-title":"Am J Med"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-60621-2","article-title":"Mortality is increased in patients with rheumatoid arthritis or diabetes compared to the general population-the Nord-Tr\u00f8ndelag health study","volume":"10","author":"Houge IS","year":"2020","unstructured":"Houge IS, Hoff M, Thomas R, Videm V. Mortality is increased in patients with rheumatoid arthritis or diabetes compared to the general population-the Nord-Tr\u00f8ndelag health study. Sci Rep. 2020, 10:3593. 10.1038\/s41598-020-60621-2","journal-title":"Sci Rep"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1038\/s41440-020-0441-1","article-title":"Traditional cardiovascular risk factors and residual disease activity are associated with atherosclerosis progression in rheumatoid arthritis patients","volume":"43","author":"Dalbeni A","year":"2020","unstructured":"Dalbeni A, Giollo A, Bevilacqua M, et al.. Traditional cardiovascular risk factors and residual disease activity are associated with atherosclerosis progression in rheumatoid arthritis patients. Hypertens Res. 2020, 43:922-8. 10.1038\/s41440-020-0441-1","journal-title":"Hypertens Res"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2013-203617","article-title":"Prevalence, extent and composition of coronary plaque in patients with rheumatoid arthritis without symptoms or prior diagnosis of coronary artery disease","volume":"73","author":"Karpouzas GA","year":"2014","unstructured":"Karpouzas GA, Malpeso J, Choi TY, Li D, Munoz S, Budoff MJ. Prevalence, extent and composition of coronary plaque in patients with rheumatoid arthritis without symptoms or prior diagnosis of coronary artery disease. Ann Rheum Dis. 2014, 73:1797-804. 10.1136\/annrheumdis-2013-203617","journal-title":"Ann Rheum Dis"},{"key":"ref16","unstructured":"Coronary artery calcium scoring (CAC). overview and clinical utilization. (2024). https:\/\/www.uptodate.com\/contents\/coronary-artery-calcium-scoring-cac-overview-and-clinical-utilization."},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCIMAGING.108.822809","article-title":"Sixty-four-slice multidetector computed tomography: an accurate imaging modality for the evaluation of coronary arteries in dilated cardiomyopathy of unknown etiology","volume":"2","author":"Andreini D","year":"2009","unstructured":"Andreini D, Pontone G, Bartorelli AL, et al.. Sixty-four-slice multidetector computed tomography: an accurate imaging modality for the evaluation of coronary arteries in dilated cardiomyopathy of unknown etiology. Circ Cardiovasc Imaging. 2009, 2:199-205. 10.1161\/CIRCIMAGING.108.822809","journal-title":"Circ Cardiovasc Imaging"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1155\/2019\/3057578","article-title":"Demographic and clinical patterns of rheumatoid arthritis in an Emirati cohort from United Arab Emirates","volume":"2019","author":"Namas R","year":"2019","unstructured":"Namas R, Joshi A, Ali Z, Al Saleh J, Abuzakouk M. Demographic and clinical patterns of rheumatoid arthritis in an Emirati cohort from United Arab Emirates. Int J Rheumatol. 2019, 2019:3057578. 10.1155\/2019\/3057578","journal-title":"Int J Rheumatol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1097\/XEB.0000000000000055","article-title":"Summarizing systematic reviews: methodological development, conduct and reporting of an umbrella review approach","volume":"13","author":"Aromataris E","year":"2015","unstructured":"Aromataris E, Fernandez R, Godfrey CM, Holly C, Khalil H, Tungpunkom P. Summarizing systematic reviews: methodological development, conduct and reporting of an umbrella review approach. Int J Evid Based Healthc. 2015, 13:132-40. 10.1097\/XEB.0000000000000055","journal-title":"Int J Evid Based Healthc"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page MJ","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, et al.. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021, 372:n71. 10.1136\/bmj.n71","journal-title":"BMJ"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1002\/art.39302","article-title":"Brief report: lack of replication of an association between anti-citrullinated fibrinogen and subclinical atherosclerosis in patients with rheumatoid arthritis","volume":"67","author":"Montes A","year":"2015","unstructured":"Montes A, Corrales A, Calaza M, Lopez-Mejias R, Parra JA, Gonz\u00e1lez-Gay MA, Gonz\u00e1lez A. Brief report: lack of replication of an association between anti-citrullinated fibrinogen and subclinical atherosclerosis in patients with rheumatoid arthritis. Arthritis Rheumatol. 2015, 67:2861-5. 10.1002\/art.39302","journal-title":"Arthritis Rheumatol"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.3390%2Fjcm11164841","article-title":"Is the calcium score useful for rheumatoid arthritis patients at low or intermediate cardiovascular risk?","volume":"11","author":"Jesson C","year":"2022","unstructured":"Jesson C, Bohbot Y, Soudet S, et al.. Is the calcium score useful for rheumatoid arthritis patients at low or intermediate cardiovascular risk?. J Clin Med. 2022, 11:4841. 10.3390%2Fjcm11164841","journal-title":"J Clin Med"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.2147%2FCLEP.S251168","article-title":"Rheumatoid arthritis as a risk factor for coronary artery calcification and obstructive coronary artery disease in patients with chest pain: a registry based cross-sectional study","volume":"12","author":"Tinggaard A","year":"2020","unstructured":"Tinggaard A, Thurah A, Andersen I, et al.. Rheumatoid arthritis as a risk factor for coronary artery calcification and obstructive coronary artery disease in patients with chest pain: a registry based cross-sectional study. Clin Epidemiol. 2020, 12:679-89. 10.2147%2FCLEP.S251168","journal-title":"Clin Epidemiol"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1111\/1756-185X.13685","article-title":"Coronary artery calcium score in female rheumatoid arthritis patients: associations with apolipoproteins and disease biomarkers","volume":"22","author":"Bernardes M","year":"2019","unstructured":"Bernardes M, Madureira A, Oliveira A, et al.. Coronary artery calcium score in female rheumatoid arthritis patients: associations with apolipoproteins and disease biomarkers. Int J Rheum Dis. 2019, 22:1841-56. 10.1111\/1756-185X.13685","journal-title":"Int J Rheum Dis"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1007\/s00296-017-3860-9","article-title":"Calcification of coronary arteries in early rheumatoid arthritis prior to anti-rheumatic therapy","volume":"38","author":"Udachkina HV","year":"2018","unstructured":"Udachkina HV, Novikova DS, Popkova TV, et al.. Calcification of coronary arteries in early rheumatoid arthritis prior to anti-rheumatic therapy. Rheumatol Int. 2018, 38:211-7. 10.1007\/s00296-017-3860-9","journal-title":"Rheumatol Int"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1007\/s00296-018-4045-x","article-title":"Dynamic of changes in coronary artery calcification in early rheumatoid arthritis patients over 18\u00a0months","volume":"38","author":"Udachkina HV","year":"2018","unstructured":"Udachkina HV, Novikova DS, Popkova TV, Kirillova IG, Markelova EI. Dynamic of changes in coronary artery calcification in early rheumatoid arthritis patients over 18\u00a0months. Rheumatol Int. 2018, 38:1217-24. 10.1007\/s00296-018-4045-x","journal-title":"Rheumatol Int"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-016-3536-y","article-title":"Ten-year progression of coronary artery, carotid artery, and aortic calcification in patients with rheumatoid arthritis","volume":"36","author":"Liu JH","year":"2017","unstructured":"Liu JH, Ng MY, Cheung T, et al.. Ten-year progression of coronary artery, carotid artery, and aortic calcification in patients with rheumatoid arthritis. Clin Rheumatol. 2017, 36:807-16. 10.1007\/s10067-016-3536-y","journal-title":"Clin Rheumatol"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1002\/art.39419","article-title":"Association of elevations of specific T cell and monocyte subpopulations in rheumatoid arthritis with subclinical coronary artery atherosclerosis","volume":"68","author":"Winchester R","year":"2016","unstructured":"Winchester R, Giles JT, Nativ S, et al.. Association of elevations of specific T cell and monocyte subpopulations in rheumatoid arthritis with subclinical coronary artery atherosclerosis. Arthritis Rheumatol. 2016, 68:92-102. 10.1002\/art.39419","journal-title":"Arthritis Rheumatol"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2013-203682","article-title":"Results from systematic screening for cardiovascular risk in outpatients with rheumatoid arthritis in accordance with the EULAR recommendations","volume":"72","author":"Primdahl J","year":"2013","unstructured":"Primdahl J, Clausen J, H\u00f8rslev-Petersen K. Results from systematic screening for cardiovascular risk in outpatients with rheumatoid arthritis in accordance with the EULAR recommendations. Ann Rheum Dis. 2013, 72:1771-6. 10.1136\/annrheumdis-2013-203682","journal-title":"Ann Rheum Dis"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1155\/2019\/6363086","article-title":"Autoantibodies as diagnostic markers and mediator of joint inflammation in arthritis","volume":"2019","author":"Fang Q","year":"2019","unstructured":"Fang Q, Ou J, Nandakumar KS. Autoantibodies as diagnostic markers and mediator of joint inflammation in arthritis. Mediators Inflamm. 2019, 2019:6363086. 10.1155\/2019\/6363086","journal-title":"Mediators Inflamm"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.140239","article-title":"Coronary and abdominal aorta calcification in rheumatoid arthritis: relationships with traditional cardiovascular risk factors, disease characteristics, and concomitant treatments","volume":"41","author":"Paccou J","year":"2014","unstructured":"Paccou J, Renard C, Liabeuf S, et al.. Coronary and abdominal aorta calcification in rheumatoid arthritis: relationships with traditional cardiovascular risk factors, disease characteristics, and concomitant treatments. J Rheumatol. 2014, 41:2137-44. 10.3899\/jrheum.140239","journal-title":"J Rheumatol"},{"key":"ref32","article-title":"C reactive protein","author":"Nehring A","year":"2023","unstructured":"Nehring A, Goyal A, Patel B. C reactive protein. StatPearls Publishing, Treasure Island (FL); 2023."},{"key":"ref33","article-title":"Erythrocyte Sedimentation Rate","author":"Tishkowshi K","year":"2023","unstructured":"Tishkowshi K, Gupta V. Erythrocyte Sedimentation Rate. StatPearls Publishing, Treasure Island (FL); 2023."},{"key":"ref34","article-title":"Comparative Value of Erythrocyte Sedimentation Rate (ESR) and C-Reactive Protein (CRP) Testing in Combination Versus Individually for the Diagnosis of Undifferentiated Patients With Suspected Inflammatory Disease or Serious Infection: A Systematic Review and Economic Analysis Canadian Agency for Drugs and Technologies in","author":"Assai N","year":"2015","unstructured":"Assai N, Blackhouse G, Campbell K, et al.. Comparative Value of Erythrocyte Sedimentation Rate (ESR) and C-Reactive Protein (CRP) Testing in Combination Versus Individually for the Diagnosis of Undifferentiated Patients With Suspected Inflammatory Disease or Serious Infection: A Systematic Review and Economic Analysis Canadian Agency for Drugs and Technologies in. Canadian Agency for Drugs and Technologies in Health, Ottawa (ON); 2015."},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1160\/TH11-09-0650","article-title":"Presence of luminal neutrophil extracellular traps in atherosclerosis","volume":"107","author":"Megens RT","year":"2012","unstructured":"Megens RT, Vijayan S, Lievens D, et al.. Presence of luminal neutrophil extracellular traps in atherosclerosis. Thromb Haemost. 2012, 107:597-8. 10.1160\/TH11-09-0650","journal-title":"Thromb Haemost"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0152925","article-title":"Increased reactive oxygen species formation and oxidative stress in rheumatoid arthritis","volume":"11","author":"Mateen S","year":"2016","unstructured":"Mateen S, Moin S, Khan AQ, Zafar A, Fatima N. Increased reactive oxygen species formation and oxidative stress in rheumatoid arthritis. PLoS One. 2016, 11:e0152925. 10.1371\/journal.pone.0152925","journal-title":"PLoS One"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0146744","article-title":"Endothelial dysfunction in rheumatoid arthritis: Mechanistic insights and correlation with circulating markers of systemic inflammation","volume":"11","author":"Totoson P","year":"2016","unstructured":"Totoson P, Maguin-Gat\u00e9 K, Nappey M, Wendling D, Demougeot C. Endothelial dysfunction in rheumatoid arthritis: Mechanistic insights and correlation with circulating markers of systemic inflammation. PLoS One. 2016, 11:e0146744. 10.1371\/journal.pone.0146744","journal-title":"PLoS One"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1002%2Fart.25009","article-title":"Inflammatory mediators and premature coronary atherosclerosis in rheumatoid arthritis","volume":"61","author":"Rho Y","year":"2009","unstructured":"Rho Y, Chung C, Oeser A, et al.. Inflammatory mediators and premature coronary atherosclerosis in rheumatoid arthritis. Arthritis Rheum. 2009, 61:1580-5. 10.1002%2Fart.25009","journal-title":"Arthritis Rheum"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1002%2Fart.37961","article-title":"Citrullination within the atherosclerotic plaque: a potential target for the anti-citrullinated protein antibody response in rheumatoid arthritis","volume":"65","author":"Sokolove J","year":"2014","unstructured":"Sokolove J, Sharpe O, Brennan M, et al.. Citrullination within the atherosclerotic plaque: a potential target for the anti-citrullinated protein antibody response in rheumatoid arthritis. Arthritis Rheum. 2014, 65:1719-24. 10.1002%2Fart.37961","journal-title":"Arthritis Rheum"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1161\/ATVBAHA.114.304475","article-title":"Anticyclic citrullinated protein antibodies are implicated in the development of cardiovascular disease in rheumatoid arthritis","volume":"34","author":"Barbarroja N","year":"2014","unstructured":"Barbarroja N, P\u00e9rez-Sanchez C, Ruiz-Limon P, et al.. Anticyclic citrullinated protein antibodies are implicated in the development of cardiovascular disease in rheumatoid arthritis. Arterioscler Thromb Vasc Biol. 2014, 34:2706-16. 10.1161\/ATVBAHA.114.304475","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2013-204024","article-title":"Performance of four current risk algorithms in predicting cardiovascular events in patients with early rheumatoid arthritis","volume":"74","author":"Arts EE","year":"2015","unstructured":"Arts EE, Popa C, Den Broeder AA, et al.. Performance of four current risk algorithms in predicting cardiovascular events in patients with early rheumatoid arthritis. Ann Rheum Dis. 2015, 74:668-74. 10.1136\/annrheumdis-2013-204024","journal-title":"Ann Rheum Dis"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2014-206879","article-title":"Prediction of cardiovascular risk in rheumatoid arthritis: performance of original and adapted SCORE algorithms","volume":"75","author":"Arts EE","year":"2016","unstructured":"Arts EE, Popa CD, Den Broeder AA, et al.. Prediction of cardiovascular risk in rheumatoid arthritis: performance of original and adapted SCORE algorithms. Ann Rheum Dis. 2016, 75:674-80. 10.1136\/annrheumdis-2014-206879","journal-title":"Ann Rheum Dis"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.1002\/art.39195","article-title":"Derivation and internal validation of an expanded cardiovascular risk prediction score for rheumatoid arthritis: a Consortium of Rheumatology Researchers of North America Registry Study","volume":"67","author":"Solomon DH","year":"2015","unstructured":"Solomon DH, Greenberg J, Curtis JR, et al.. Derivation and internal validation of an expanded cardiovascular risk prediction score for rheumatoid arthritis: a Consortium of Rheumatology Researchers of North America Registry Study. Arthritis Rheumatol. 2015, 67:1995-2003. 10.1002\/art.39195","journal-title":"Arthritis Rheumatol"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.2147%2FVHRM.S275739","article-title":"PCSK9 inhibitors in the management of cardiovascular risk: a practical guidance","volume":"20","author":"Jia X","year":"2022","unstructured":"Jia X, RIfai M, Saeed A, et al.. PCSK9 inhibitors in the management of cardiovascular risk: a practical guidance. Vasc Health Risk Manag. 2022, 20:555-66. 10.2147%2FVHRM.S275739","journal-title":"Vasc Health Risk Manag"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.1515\/jom-2023-0082","article-title":"The role of aspirin, statins, colchicine, and IL-1 inhibitors in prevention of cardiovascular events: a systematic integrative review","volume":"124","author":"Arboleda V","year":"2024","unstructured":"Arboleda V, Hackworth A, Bonnice S, et al.. The role of aspirin, statins, colchicine, and IL-1 inhibitors in prevention of cardiovascular events: a systematic integrative review. J Osteopath Med. 2024, 124:97-106. 10.1515\/jom-2023-0082","journal-title":"J Osteopath Med"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1615664","article-title":"Evolocumab and clinical outcomes in patients with cardiovascular disease","volume":"376","author":"Sabatine MS","year":"2017","unstructured":"Sabatine MS, Giugliano RP, Keech AC, et al.. Evolocumab and clinical outcomes in patients with cardiovascular disease. N Engl J Med. 2017, 376:1713-22. 10.1056\/NEJMoa1615664","journal-title":"N Engl J Med"},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.1002%2Fart.30239","article-title":"Low frequency of primary lipid screening among Medicare patients with rheumatoid arthritis","volume":"63","author":"Bartels C","year":"2011","unstructured":"Bartels C, Kind A, Everett C, et al.. Low frequency of primary lipid screening among Medicare patients with rheumatoid arthritis. Arthritis Rheum. 2011, 63:1221-30. 10.1002%2Fart.30239","journal-title":"Arthritis Rheum"},{"key":"ref48","doi-asserted-by":"publisher","DOI":"10.1186\/ar4118","article-title":"Suboptimal cardiovascular risk factor identification and management in patients with rheumatoid arthritis: a cohort analysis","volume":"14","author":"Desai SS","year":"2012","unstructured":"Desai SS, Myles JD, Kaplan MJ. Suboptimal cardiovascular risk factor identification and management in patients with rheumatoid arthritis: a cohort analysis. Arthritis Res Ther. 2012, 14:R270. 10.1186\/ar4118","journal-title":"Arthritis Res Ther"},{"key":"ref49","doi-asserted-by":"publisher","DOI":"10.1186\/s13075-019-1817-y","article-title":"Awareness and perceived risk of cardiovascular disease among individuals living with rheumatoid arthritis is low: results of a systematic literature review","volume":"21","author":"Ghosh-Swaby OR","year":"2019","unstructured":"Ghosh-Swaby OR, Kuriya B. Awareness and perceived risk of cardiovascular disease among individuals living with rheumatoid arthritis is low: results of a systematic literature review. Arthritis Res Ther. 2019, 21:33. 10.1186\/s13075-019-1817-y","journal-title":"Arthritis Res Ther"},{"key":"ref50","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)30925-9","article-title":"Global burden of 369 diseases and injuries in 204 countries and territories, 1990-2019: a systematic analysis for the global burden of disease study 2019","volume":"396","year":"2020","unstructured":"Global burden of 369 diseases and injuries in 204 countries and territories, 1990-2019. a systematic analysis for the global burden of disease study 2019. Lancet. 2020, 396:1204-22. 10.1016\/S0140-6736(20)30925-9","journal-title":"Lancet"},{"key":"ref51","doi-asserted-by":"publisher","DOI":"10.1155%2F2021%2F5523516","article-title":"Protective effects of estrogen on cardiovascular disease mediated by oxidative stress","author":"Xiang D","year":"2021","unstructured":"Xiang D, Liu Y, Zhou S, et al.. Protective effects of estrogen on cardiovascular disease mediated by oxidative stress. Oxid Med Cell Longev. 2021, 10.1155%2F2021%2F5523516","journal-title":"Oxid Med Cell Longev"},{"key":"ref52","doi-asserted-by":"crossref","DOI":"10.4103\/0019-5359.26612","article-title":"Pregnancy and rheumatoid arthritis","volume":"60","author":"Tandon VR","year":"2006","unstructured":"Tandon VR, Sharma S, Mahajan A, Khajuria V, Kumar A. Pregnancy and rheumatoid arthritis. Indian J Med Sci. 2006, 60:334-44.","journal-title":"Indian J Med Sci"},{"key":"ref53","doi-asserted-by":"publisher","DOI":"10.1093\/humupd\/dmi008","article-title":"Sex hormones and the immune response in humans","volume":"11","author":"Bouman A","year":"2005","unstructured":"Bouman A, Heineman MJ, Faas MM. Sex hormones and the immune response in humans. Hum Reprod Update. 2005, 11:411-23. 10.1093\/humupd\/dmi008","journal-title":"Hum Reprod Update"},{"key":"ref54","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.142.3.371","article-title":"Sex hormones and the genesis of autoimmunity","volume":"142","author":"Ackerman LS","year":"2006","unstructured":"Ackerman LS. Sex hormones and the genesis of autoimmunity. Arch Dermatol. 2006, 142:371-6. 10.1001\/archderm.142.3.371","journal-title":"Arch Dermatol"},{"key":"ref55","doi-asserted-by":"publisher","DOI":"10.1080\/13685538.2018.1482487","article-title":"The relationship between circulating testosterone and inflammatory cytokines in men","volume":"22","author":"Mohamad NV","year":"2019","unstructured":"Mohamad NV, Wong SK, Wan Hasan WN, Jolly JJ, Nur-Farhana MF, Ima-Nirwana S, Chin KY. The relationship between circulating testosterone and inflammatory cytokines in men. Aging Male. 2019, 22:129-40. 10.1080\/13685538.2018.1482487","journal-title":"Aging Male"},{"key":"ref56","doi-asserted-by":"publisher","DOI":"10.3390\/jcm7120549","article-title":"Do androgens modulate the pathophysiological pathways of inflammation? Appraising the contemporary evidence","volume":"7","author":"Traish A","year":"2018","unstructured":"Traish A, Bolanos J, Nair S, Saad F, Morgentaler A. Do androgens modulate the pathophysiological pathways of inflammation? Appraising the contemporary evidence. J Clin Med. 2018, 7:10.3390\/jcm7120549","journal-title":"J Clin Med"},{"key":"ref57","doi-asserted-by":"publisher","DOI":"10.1002\/art.22418","article-title":"Glucocorticoids and cardiovascular events in rheumatoid arthritis: a population-based cohort study","volume":"56","author":"Davis JM 3rd","year":"2007","unstructured":"Davis JM 3rd, Maradit Kremers H, Crowson CS, et al.. Glucocorticoids and cardiovascular events in rheumatoid arthritis: a population-based cohort study. Arthritis Rheum. 2007, 56:820-30. 10.1002\/art.22418","journal-title":"Arthritis Rheum"},{"key":"ref58","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2014-206624","article-title":"The effects of tumour necrosis factor inhibitors, methotrexate, non-steroidal anti-inflammatory drugs and corticosteroids on cardiovascular events in rheumatoid arthritis, psoriasis and psoriatic arthritis: a systematic review and meta-analysis","volume":"74","author":"Roubille C","year":"2015","unstructured":"Roubille C, Richer V, Starnino T, et al.. The effects of tumour necrosis factor inhibitors, methotrexate, non-steroidal anti-inflammatory drugs and corticosteroids on cardiovascular events in rheumatoid arthritis, psoriasis and psoriatic arthritis: a systematic review and meta-analysis. Ann Rheum Dis. 2015, 74:480-9. 10.1136\/annrheumdis-2014-206624","journal-title":"Ann Rheum Dis"},{"key":"ref59","doi-asserted-by":"publisher","DOI":"10.1016%2Fj.jacc.2018.10.066","article-title":"Coronary artery plaque characteristics associated with adverse outcomes in the SCOT-HEART study","volume":"73","author":"Williams M","year":"2019","unstructured":"Williams M, Moss A, Dweck M, et al.. Coronary artery plaque characteristics associated with adverse outcomes in the SCOT-HEART study. J Am Coll Cardiol. 2019, 73:291-301. 10.1016%2Fj.jacc.2018.10.066","journal-title":"J Am Coll Cardiol"},{"key":"ref60","doi-asserted-by":"publisher","DOI":"10.1097\/MCA.0000000000001103","article-title":"Low attenuation plaque volume on coronary computed tomography angiography is associated with plaque progression","volume":"33","author":"Wang GX","year":"2022","unstructured":"Wang GX, Yang L, Yang Y, Zhang D, Yu J, Wen L. Low attenuation plaque volume on coronary computed tomography angiography is associated with plaque progression. Coron Artery Dis. 2022, 33:176-81. 10.1097\/MCA.0000000000001103","journal-title":"Coron Artery Dis"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/290559-coronary-artery-calcification-in-rheumatoid-arthritis-patients-a-systematic-review","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,30]],"date-time":"2024-09-30T14:54:19Z","timestamp":1727708059000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/290559-coronary-artery-calcification-in-rheumatoid-arthritis-patients-a-systematic-review"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,30]]},"references-count":60,"URL":"https:\/\/doi.org\/10.7759\/cureus.70517","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9,30]]}}}